Pfizer Holds Out Hope For C. Diff Vaccine Despite Clinical, Commercial Failures

Sanofi’s Candidate Failed, Merck’s Zinplava Never Gained Traction

 
• By Mandy Jackson
  
Clostridium difficile bacteria, computer illustration
C. diff is most common in older adults • Source: Alamy

More from Clinical Trials

More from R&D